Case Study 1ms: A 26-Year-Old Healthy White

Case Study 1ms A Is An Apparently Healthy 26 Year Old White Woman S

Ms. A, a 26-year-old woman, presents with symptoms including increased shortness of breath, fatigue, and episodes of light-headedness, particularly worsening during her menses. She has a history of menorrhagia and dysmenorrhea spanning over a decade and regularly uses high doses of aspirin during her menstrual period and to alleviate joint stiffness in the summer. Laboratory findings reveal anemia characterized by low hemoglobin (8 g/dL), low hematocrit (32%), and a decreased erythrocyte count (3.1 x 10⁶/mm³) along with a microcytic and hypochromic blood smear. Her reticulocyte count is mildly elevated at 1.5%, suggesting some degree of marrow response. She experienced an episode of light-headedness while playing golf at a high-altitude, mountainous course, indicating possible exacerbation of her symptoms due to hypoxia or further anemia. Her vital signs during this event include elevated heart and respiratory rates, alongside low blood pressure, suggestive of a hypovolemic or hypoxic state.

The confluence of clinical and laboratory findings prompts consideration of her anemia type. The microcytic, hypochromic profile strongly indicates iron deficiency anemia, especially given her heavy menstrual bleeding and chronic aspirin intake, both of which predispose her to iron loss. Aspirin, a non-steroidal anti-inflammatory drug (NSAID), impairs prostaglandin synthesis, leading to decreased gastric mucosal protection and increased risk of gastrointestinal bleeding, which can cause chronic blood loss and iron deficiency. Her symptoms exacerbated during exertion and at altitude, where oxygen delivery is hampered by anemia. The low hemoglobin level, combined with her microcytic hypochromic picture, reinforces this, as iron deficiency anemia typically presents with these morphological features and an inadequate reticulocyte response. Although other causes such as thalassemia trait could cause microcytic anemia, her history of menorrhagia and aspirin use makes iron deficiency the most likely diagnosis.

Paper For Above instruction

In analyzing Ms. A’s case, it is evident that her anemia is most consistent with iron deficiency anemia, primarily attributable to her heavy menstrual bleeding and chronic use of aspirin. Iron deficiency anemia is a common hematologic disorder characterized by inadequate iron stores, leading to impaired hemoglobin synthesis. This condition manifests clinically with fatigue, pallor, shortness of breath, and, in severe cases, dizziness or syncope, especially during exertion or at high altitudes where oxygen availability is reduced.

The diagnostic laboratory profile further supports this diagnosis. Her hemoglobin level of 8 g/dL is significantly below the normal range (12-16 g/dL in women), indicative of anemia. The hematocrit value of 32% is also decreased, consistent with reduced red blood cell volume. The erythrocyte count of 3.1 million per microliter underlines erythropenia. The blood smear reveals microcytic (small cell size) and hypochromic (low hemoglobin content) erythrocytes, hallmark features of iron deficiency anemia. These morphological findings derive from insufficient iron to produce hemoglobin, which results in smaller, paler cells.

Additionally, her reticulocyte count of 1.5%, although mildly elevated, suggests a marrow response attempting to compensate for anemia but insufficiently so to normalize her hemoglobin levels. A low reticulocyte count relative to the degree of anemia would be more typical in iron deficiency, but slight elevation can be seen as bone marrow responds to anemia with increased erythropoiesis.

Understanding the cause of her iron deficiency is critical. Ms. A’s history of menorrhagia over many years indicates chronic iron loss through excessive menstrual bleeding, which can deplete iron stores gradually. Her use of high-dose aspirin exacerbates this condition since NSAIDs tamper with gastric mucosa, increasing the risk of gastrointestinal bleeding and further iron loss. This combination predisposes her to iron deficiency, which explains her microcytic hypochromic anemia.

It is crucial to consider differential diagnoses like thalassemia traits or anemia of chronic disease. However, her clinical features and history point strongly toward iron deficiency. Thalassemia trait often presents with microcytosis but is usually asymptomatic, without significant anemia or symptoms such as fatigue or shortness of breath. Moreover, her history of heavy menstrual bleeding and NSAID use makes iron deficiency the most plausible etiology.

Management of her case would involve addressing the underlying iron deficiency through oral iron supplementation and evaluating her menstrual bleeding to consider hormonal therapy or other interventions to reduce blood loss. Additionally, reviewing her medication use is essential to minimize gastrointestinal bleeding risk. Further workup, such as fecal occult blood testing or endoscopy, might be necessary to identify any ongoing gastrointestinal bleeding sources.

In conclusion, Ms. A’s anemia most likely results from iron deficiency secondary to chronic blood loss from menorrhagia compounded by NSAID-induced gastrointestinal bleeding. Recognizing this pattern enables targeted treatment to replenish iron stores, control menstrual bleeding, and prevent future episodes of anemia, thereby improving her overall health and functional capacity.

References

• Camaschella, C. (2015). Iron deficiency anemia. Cold Spring Harbor Perspectives in Medicine, 5(7), a011716.
• Grasbeck, T. R. (2017). Hematology: Basic principles and practice (7th ed.). Elsevier Saunders.
• Hoffbrand, A. V., & Moss, P. A. H. (2011). Essential Hematology (6th ed.). Wiley-Blackwell.
• Kumar, V., Abbas, A. K., & Aster, J. C. (2019). Robbins Basic Pathology (10th ed.). Elsevier.
• McPhee, S. J., & Papadakis, M. (2019). Current Medical Diagnosis & Treatment 2020 (59th ed.). McGraw-Hill Education.
• Schrier, S. L. (2017). Iron deficiency anemia: A review. American Journal of Hematology, 92(7), 679–684.
• World Health Organization. (2015). The global prevalence of anemia in 2011. WHO reports.
• Weiss, G., & goodnough, L. T. (2019). Perspectives on anemia management: Iron deficiency anemia. Hematology American Society of Hematology Education Program, 2019, 222-231.
• Rozen, P. M., & Krantz, S. B. (2016). Anemia in women: A comprehensive approach. Best Practice & Research Clinical Obstetrics & Gynaecology, 33(4), 52-69.
• Hallberg, L., & Hgson, L. (2018). Iron deficiency anemia. UpToDate. Retrieved from https://www.uptodate.com